POTASSIUM CHLORIDE sustained-release oral

Prescription under medical supervision

Therapeutic action

– Potassium supplement


– Hypokalaemia induced by :
• thiazide diuretics (e.g. hydrochlorothiazide)
• loop diuretics (e.g. furosemide)

Forms and strengths

– 600 mg potassium chloride sustained-release tablet (8 mmol of K+)


– Adult: 15 to 25 mmol daily = 1 tablet 2 to 3 times daily
– Do not exceed indicated doses if potassium serum levels cannot be measured.


– According to clinical response and duration of diuretic treatment

Contra-indications, adverse effects, precautions

– Administer with caution and reduce dosage in elderly patients and in patients with renal impairment (risk of hyperkalaemia).
– Do not combine with spironolactone and angiotensin-converting-enzyme inhibitors (e.g. enalapril).
– May cause: hyperkalaemia, gastroduodenal ulcerations, diarrhoea, nausea and vomiting.
– Pregnancy: no contra-indication
– Breast-feeding: no contra-indication


– Take with or at the end meals in order to reduce the risk of gastrointestinal ulcerations.
– Hypokalaemia is defined as a serum potassium concentration below 3.5 mmol/litre.
– If tablets are not available, a lack of potassium may be corrected by a diet rich in dates, bananas, mangos, oranges, tomatoes, etc.
– Storage: below 25 °C -